Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukemia: Results of the EORTC CLG 58881 and 58951 trials,Leukemia

当前位置： X-MOL 学术 › Leukemia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukemia: Results of the EORTC CLG 58881 and 58951 trials
Leukemia ( IF 12.8 ) Pub Date : , DOI: 10.1038/leu.2017.289
C Piette ₁ , S Suciu ₂ , E Clappier _{3,

4} , Y Bertrand ₅ , S Drunat ₃ , S Girard ₆ , K Yakouben ₇ , G Plat ₈ , N Dastugue ₈ , F Mazingue ₉ , N Grardel ₉ , N van Roy ₁₀ , A Uyttebroeck ₁₁ , V Costa ₁₂ , O Minckes ₁₃ , N Sirvent ₁₄ , P Simon ₁₅ , P Lutz ₁₆ , A Ferster ₁₇ , C Pluchart ₁₈ , M Poirée ₁₉ , C Freycon ₂₀ , M-F Dresse ₁ , F Millot ₂₁ , C Chantrain ₂₂ , J van der Werff Ten Bosch ₂₃ , K Norga ₂₄ , C Gilotay ₂ , P-S Rohrlich ₁₉ , Y Benoit ₂₅ , H Cavé _{3,

4}

Affiliation

University Department of Pediatrics, Pediatric Onco-Hematology, CHR Citadelle, Liège, Belgium.
EORTC Headquarters, Brussels, Belgium.
Département de Génétique, Hôpital Robert Debré, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
Institut Universitaire d'Hématologie, Université Paris Diderot, Paris-Sorbonne-Cité, Paris, France.
Department of Pediatric Hematology, IHOP, Hospices Civils de Lyon and Claude Bernard Lyon University, Lyon, France.
Laboratory of Hematology, East Lyon University Hospital, Hospices Civils de Lyon, Lyon, France.
Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Robert Debré, Service d'Immuno-Hématologie pédiatrique, Paris, France.
Department of Pediatric Onco-Hematology, Purpan University Hospital, Toulouse, France.
Department of Pediatric Hematology-Oncology, Lille University Hospital, Lille, France.
Center for Medical Genetics, Ghent University, Ghent, Belgium.
Department of Pediatrics, University Hospital Gasthuisberg, Leuven, Belgium.
Department of Pediatrics, Portuguese Oncology Institute, Porto, Portugal.
Department of Pediatric Onco-Hematology, Caen University Hospital, Caen, France.
Department of Pediatric Onco-Hematology, Montpellier University Hospital, Montpellier, France.
Department of Pediatric Onco-Hematology, Besançon University Hospital, Besançon, France.
Department of Hematology, Hautepierre University Hospital, Strasbourg, France.
Department of Pediatric Onco-Hematology, Hôpital Universitaire des Enfants Reine Fabiola (ULB), Brussels, Belgium.
Department of Pediatric Onco-Hematology, Reims University Hospital, Reims, France.
Department of Pediatric Onco-Hematology, Nice University Hospital, Nice, France.
Department of Pediatric Onco-Hematology, Grenoble University Hospital, Grenoble, France.
Department of Pediatric Onco-Hematology, Poitiers University Hospital, Poitiers, France.
Department of Pediatrics, Clinique de l'Espérance, CHC, Liège, Belgium.
Department of Pediatric Onco-Hematology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Pediatric Onco-Hematology Unit, Antwerp University Hospital, Antwerp, Belgium.
Department of Pediatric Hematology-Oncology, Ghent University Hospital, Ghent, Belgium.

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukemia: Results of the EORTC CLG 58881 and 58951 trials

Leukemia, Published online: 19 September 2017; doi:10.1038/leu.2017.289

中文翻译：

药物对 ETV6-RUNX1 阳性儿童 B 细胞前体急性淋巴细胞白血病结果的不同影响：EORTC CLG 58881 和 58951 试验的结果

药物对 ETV6-RUNX1 阳性儿童 B 细胞前体急性淋巴细胞白血病结果的不同影响：EORTC CLG 58881 和 58951 试验的结果

Leukemia, Published online: 19 September 2017; doi:10.1038/leu.2017.289

更新日期：2017-09-19

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11